Margaret C. Harney
A registered patent agent, Margaret Harney centers her practice on patent prosecution related to biotechnology and pharmaceutical matters. Her practice encompasses a broad range of subjects, including antibody therapeutics, manufacturing and purification of biologics, DNA/protein sequencing, and therapeutic methods. Margaret has experience assisting clients through the numerous phases of patent portfolio management from prosecution of U.S. and foreign patent applications, due diligence related to intellectual property acquisitions, to post-grant proceedings at the U.S. Patent and Trademark Office. Prior to becoming a patent agent, Margaret received her B.A. in neuroscience from Wellesley College where she conducted research into mechanisms underlying affective disorders.
- Representing Takeda in parallel patent litigations in the US District Court for the District of New Jersey defending its ENTYVIO® (vedolizumab) technology against biosimilar entrants. Brought under the Biologics Price Competition and Innovation Act, the actions target Polpharma Biologics' PB016 product, slated for commercialization with Fresenius Kabi, and Alvotech's AVT16 product, developed and manufactured by Alvotech for commercialization by Teva. The matters require coordinated enforcement of a multipatent portfolio protecting multiple aspects of Takeda's ENTYVIO® technology.
- Wellesley College, 2019, B.A., Neuroscience, magna cum laude, Phi Beta Kappa
- US Patent and Trademark Office
Member, Practice Group of the Year, Intellectual Property, Law360 (2024)